Akebia Therapeutics (AKBA) Other Operating Expenses (2013 - 2026)
Akebia Therapeutics (AKBA) reported Other Operating Expenses of $379000.0 for Q1 2026, down 2.07% year-over-year from $387000.0 in Q1 2025, and down 98.56% quarter-over-quarter from $26.2 million in Q4 2025.
Akebia Therapeutics (AKBA) Other Operating Expenses (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has 10 years of Other Operating Expenses data on file, last reported at $379000.0 in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $379000.0, down 2.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.8 million (up 7074.94% YoY), and the FY2023 annual result was -$500000.0, changed N/A from the prior year.
- Other Operating Expenses fell to $379000.0 in Q1 2026 per AKBA's latest filing, from $26.2 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $26.2 million in Q4 2025 and troughed at -$500000.0 in Q2 2023.
- A 5-year average of $3.2 million and a median of $387000.0 in 2025 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses tumbled 62.14% in 2023, then jumped 104.12% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at $449000.0 in 2022, then slumped by 211.36% to -$500000.0 in 2023, then jumped by 169.4% to $347000.0 in 2024, then jumped by 7459.08% to $26.2 million in 2025, then sank by 98.56% to $379000.0 in 2026.
- Business Quant data shows AKBA's Other Operating Expenses at $379000.0 in Q1 2026, $26.2 million in Q4 2025, and $578000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 379,000.00 |
| Dec 31, 2025 | 26.23 Mn |
| Sep 30, 2025 | 578,000.00 |
| Jun 30, 2025 | 580,000.00 |
| Mar 31, 2025 | 387,000.00 |
| Mar 31, 2024 | 347,000.00 |
| Jun 30, 2023 | -500,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Mar 31, 2022 | 449,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 870,000.00 |
| Jun 30, 2021 | 35.11 Mn |
| Mar 31, 2021 | 695,000.00 |
| Dec 31, 2020 | 327,000.00 |
| Sep 30, 2020 | 210,000.00 |
| Jun 30, 2020 | 544,000.00 |
| Mar 31, 2020 | 676,000.00 |
| Dec 31, 2019 | 469,000.00 |
| Sep 30, 2019 | 329,000.00 |
| Jun 30, 2019 | 295,000.00 |